Pyxis Oncology (PYXS) Short-term Investments (2021 - 2025)

Pyxis Oncology (PYXS) has 5 years of Short-term Investments data on file, last reported at $1.5 million in Q4 2025.

• Short-term Investments for Q4 2025 came in at $1.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (changed 0.0% YoY), and the FY2025 annual result was $1.5 million, changed 0.0% from the prior year.
• Short-term Investments was little changed at $1.5 million in Q4 2025 per PYXS's latest filing, from $1.5 million in the prior quarter.
• Over five years, Short-term Investments peaked at $129.1 million in Q1 2024 and troughed at $1.5 million in Q4 2021.
• A 5-year average of $32.1 million and a median of $1.5 million in 2021 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 8667.66% in 2024 and fell as far as 98.76% in 2024.
• A 5-year view of Short-term Investments shows it stood at $1.5 million in 2021, then changed by 0.0% to $1.5 million in 2022, then jumped by 7347.96% to $109.6 million in 2023, then sank by 98.66% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
• Business Quant data shows PYXS's Short-term Investments at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $78.2 million in Q2 2025.